-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

Benzinga·09/25/2026 14:49:10
Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.